Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00228865 · ClinicalTrials.gov registry record · Phase 2

Clinical Effects of Pulsatile Insulin Delivery on Cognitive Function- Phase 1

A Phase 2 study, sponsored by Florida Atlantic University.

Terminated
Registry status
Phase 2
Development phase
75
Enrollment target

NCT00228865: Clinical Trial Phase 2 study, sponsored by Florida Atlantic University.

NCT00228865 is a Phase 2 study that was terminated before completion, run by Florida Atlantic University. The registered enrollment target is 75 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00228865, a Phase 2 study, was terminated before completion, sponsored by Florida Atlantic University.

TERMINATED
Registry status
Phase 2
Development phase
75 participants
Enrollment target

Study Summary

To determine if restoring normal metabolic function in patients with either Type I or Type II Diabetes can improve overall cognitive function. Patients are treated once a week with pulsatile intravenous insulin therapy mimicking normal insulin secretion and high amounts of oral glucose consumption.

Interventions

  • PROCEDURE Pulsatile IV insulin therapy
  • PROCEDURE Effects of Pulsatile IV Insulin on Cognitive functions

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2003-06
Est. Completion 2009-08
Phase Phase 2
Florida Atlantic University

27 total trials

Why NCT00228865 stopped before completion

NCT00228865 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% lower).

The record links to 0 conditions, and to 2 interventions - of which Pulsatile IV insulin therapy is the first listed.

NCT00228865 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00228865 about?

NCT00228865 is a clinical study titled "Clinical Effects of Pulsatile Insulin Delivery on Cognitive Function- Phase 1". To determine if restoring normal metabolic function in patients with either Type I or Type II Diabetes can improve overall cognitive function. Patients are treated once a week with pulsatile intravenous insulin therapy mimicking normal insulin secretion and high amounts of oral glucose consumption.

What is the current status of trial NCT00228865?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 75 participants. The study started on 2003-06. Estimated completion is 2009-08.

What interventions are being tested in trial NCT00228865?

The interventions under investigation include: Pulsatile IV insulin therapy (PROCEDURE), Effects of Pulsatile IV Insulin on Cognitive functions (PROCEDURE).

Who is sponsoring clinical trial NCT00228865?

This trial is sponsored by Florida Atlantic University, which has 27 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00228865's enrollment target sits among peer trials

75 900th of 2000 higher than 1,081 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00228865, the US trial registry maintained by the National Library of Medicine. NCT00228865 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.